207
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children

, , , &
Pages 13-21 | Published online: 18 Dec 2015

References

  • JorgensenJOMollerNLauritzenTChristiansenJSPulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indicesThe Journal of Clinical Endocrinology and Metabolism1990706161616232189886
  • CutfieldWLindbergAAlbertsson WiklandKChatelainPRankeMBWiltonPFinal height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International BoardActa Paediatrica199988428727510102057
  • RankeMBLindbergAAlbertsson-WiklandKWiltonPPriceDAReiterEOIncreased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0–3 years) with idiopathic GH Deficiency: analysis of data from KIGSThe Journal of Clinical Endocrinology and Metabolism20059041966197115634724
  • LeschekEWRoseSRYanovskiJAEffect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trialThe Journal of Clinical Endocrinology and Metabolism20048973140314815240584
  • AmatoGMazziottiGDi SommaCRecombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injectionsThe Journal of Clinical Endocrinology and Metabolism200085103720372511061530
  • LaursenTGravholtCHHeickendorffLLong-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adultsThe Journal of Clinical Endocrinology and Metabolism20018631222122811238512
  • SmithSLHindmarshPCBrookCGCompliance with growth hormone treatment – are they getting it?Archives of Disease in Childhood199368191938435018
  • DesrosiersPO’BrienFBlethenSPatient outcomes in the GHMonitor: the effect of delivery device on compliance and growthPediatric Endocrinology Reviews: PER20052Suppl 332733116456500
  • KapoorRRBurkeSASparrowSEMonitoring of concordance in growth hormone therapyArchives of Disease in Childhood200893214714817768149
  • ClarkROlsonKFuhGLong-acting growth hormones produced by conjugation with polyethylene glycolThe Journal of Biological Chemistry19962713621969219778703002
  • TannerJMHealyMJRGoldsteinHCameronNAssessment of Skeletal Maturity and Prediction of Adult Height (TW3 Method)3rd edLondonW.B. Saunders2001
  • RosenfeldRGBakkerBCompliance and persistence in pediatric and adult patients receiving growth hormone therapyEndocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists2008142143154
  • ReiterEOAttieKMMoshangTJrA multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiencyThe Journal of Clinical Endocrinology and Metabolism200186104700470611600528
  • BoothCGasparHBPegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)Biologics: Targets & Therapy2009334935819707420
  • PeterFSavoyCJiHJJuhaszMBidlingmaierMSaengerPPharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiencyEuropean Journal of Endocrinology/European Federation of Endocrine Societies2009160334935519074465
  • BaoXLShiYFDuYCLiuRDengJYGaoSMPrevalence of growth hormone deficiency of children in BeijingChinese Medical Journal199210554014051499371
  • BidlingmaierMKimJSavoyCComparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiencyThe Journal of Clinical Endocrinology and Metabolism20069182926293016720652
  • WebsterRXieRDidierEPEGylation of somatropin (recombinant human growth hormone): impact on its clearance in humansXenobiotica; the Fate of Foreign Compounds in Biological Systems2008381013401351
  • SalvatoriRGrowth hormone and IGF-1Reviews in Endocrine & Metabolic Disorders200451152314966386
  • KellerAWuZKratzschJPharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administrationEuropean Journal of Endocrinology/European Federation of Endocrine Societies2007156664765317535864
  • SilvermanBLBlethenSLReiterEOAttieKMNeuwirthRBFordKMA long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiencyJournal of Pediatric Endocrinology & Metabolism: JPEM200215Suppl 271572212092685
  • TourainePD’SouzaGAKouridesILipoatrophy in GH deficient patients treated with a long-acting pegylated GHEuropean Journal of Endocrinology/European Federation of Endocrine Societies2009161453354019654233
  • TobiumeHKanzakiSHidaSSerum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapyThe Journal of Clinical Endocrinology and Metabolism1997827205620619215272
  • CiresiAAmatoMCCriscimannaAMetabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiencyEuropean Journal of Endocrinology/European Federation of Endocrine Societies2007156335336017322495
  • KearneyTde GallegosCNProudlerAEffects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjectsMetabolism: Clinical and Experimental2003521505912524662
  • RezvaniIDiGeorgeAMDowshenSABourdonyCJAction of human growth hormone (hGH) on extrathyroidal conversion of thyroxine (T4) to triiodothyronine (T3) in children with hypopituitarismPediatric Research1981151697208169
  • WebsterRElliottVParkBKPEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicalsVeroneseFMPEGylated Protein Drugs: Basic Science and Clinical Applications (Milestones in Drug Therapy)Birkhauser2009127146
  • RudmannDGAlstonJTHansonJCHeidelSHigh molecular weight polyethylene glycol cellular distribution and PEG-associated cytoplasmic vacuolation is molecular weight dependent and does not require conjugation to proteinsToxicologic Pathology201341797098323788571
  • KronenbergSBaumannAde HaanLCurrent challenges and opportunities in nonclinical safety testing of biologicsDrug Discovery Today20131823–241138114323942260
  • CHMP Safety Working Party’s response to the PDCO regarding the use of PEGylated drug products in the paediatric population Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000087.jspAccessed December 22, 2014
  • GuiottoACanevariMPozzobonMMoroSOrsoliniPVeroneseFMAnchimeric assistance effect on regioselective hydrolysis of branched PEGs: a mechanistic investigationBioorganic & Medicinal Chemistry200412195031503715351387